Investment strengthens genetic testing expertise in Canada
BRAMPTON, ON, Oct. 3, 2013 /CNW/ - Gamma-Dynacare Medical Laboratories
(Gamma-Dynacare) announced today that it has completed the acquisition
of a controlling interest in Impact Genetics Inc. (Impact Genetics), a
Toronto-based laboratory specializing in high-complexity,
disease-specific genetic testing.
"We welcome this opportunity to strengthen Gamma-Dynacare's position as
a leading Canadian reference laboratory," said Naseem Somani, President
and Chief Executive Officer, Gamma-Dynacare Medical Laboratories.
"Experts around the world seek out the specialized genetic testing
expertise of Impact Genetics. This investment brings to Gamma-Dynacare
expanded capabilities in molecular medicine, oncology and genetic
testing for rare diseases that will enhance our continued growth in the
field of personalized medicine."
Impact Genetics is recognized by oncologists and geneticists around the
world as a leader in genetic testing for rare diseases. With a test
menu including Retinoblastoma RB, Hereditary Hemorrhagic Telangiectasia (HHT), Von Hippel-Lindau Syndrome VHL and Gene Copy Number Analysis, Impact Genetics serves clients throughout North America, Asia and
Europe. New tests for Uveal Melanoma and Inherited Leukemia will soon
"This exciting partnership will provide Canadians with better genetics
services and build on local expertise and talent in this rapidly
expanding market," said Franny Jewett, CEO, Impact Genetics.
Over the coming months, Impact Genetics' operations will move to
Gamma-Dynacare's centre of excellence for pathology, immunopathology,
genetics and pharmacogenomics testing in Bowmanville Ontario, near
Toronto. Ms. Jewett, Medical Director Dr. Brenda Gallie and the entire
Impact Genetics team will remain in their respective roles with the
"It was Gamma-Dynacare's commitment to molecular medicine, reputation
for quality and expertise in high volume laboratory test services that
attracted us. Our scientific discoveries will have global impact
because this partnership allows us to grow and deliver on our mission
of providing cost-effective, high quality genetic testing for rare
diseases," explained Dr. Gallie, an internationally recognized leader
in retinoblastoma genetics, biology and clinical care.
About Impact Genetics Inc.
Impact Genetics is committed to providing high quality genetic
diagnostics for rare diseases to as many people as possible. Impact's
tests improve the health of entire families by:
identifying members of a family who carry a disease-causing mutation;
focusing treatment on relatives at risk; and
eliminating from surveillance relatives who are not at risk.
Quality: Impact Genetics' tests are equal to or exceed the most accurate and
sensitive tests available. This is achieved through medical and
scientific expert oversight, leading edge technology, continual test
refinement and comprehensive reporting.
Service excellence: Impact Genetics' exceptional service supports referring healthcare
professionals and payers and improves outcomes for patients.
Expertise: Impact focuses on genetic testing for diseases initiated by novel
mutations that require a high degree of gene and disease-specific
knowledge. For each disease, we collaborate with genetics, medical,
scientific and informatics experts, and where consented, provide access
to anonymous clinical test data for research and publication.
Impact has been providing clinical genetic testing to patients from 25
countries since 1999 and is the world leader in retinoblastoma
About Gamma-Dynacare Medical Laboratories
Providing Information. Impacting Lives. Caring for People. By living this mission, Gamma-Dynacare Medical Laboratories will
achieve its vision of becoming the trusted leader in transforming
laboratory information and services into solutions that improve health,
wellness and the Canadian health care system.
Gamma-Dynacare is one of Canada's largest and most respected providers
of laboratory services and solutions, with more than 50 years of
experience serving Canadians. Headquartered in Brampton, Ontario,
Gamma-Dynacare operates laboratories in Ontario (Brampton, Bowmanville,
London, Ottawa and Thunder Bay), Quebec (Saint-Laurent and Laval),
Manitoba (Winnipeg) and Alberta (Edmonton).
In addition, Gamma-Dynacare operates more than 200 Patient Services
Centres in Ontario, Quebec, Manitoba, Saskatchewan and Alberta.
Gamma-Dynacare's 2,400 skilled and dedicated employees perform 50
million tests each year, playing a key role in the prevention and
diagnosis of disease and the treatment of patients.
SOURCE: Gamma-Dynacare Medical Laboratories
For further information:
Vice-President, Strategic Planning and Corporate Communications
Gamma-Dynacare Medical Laboratories
(905) 790-3515 or 1-866-790-3515, ext. 5381
(647) 478-4902 or 1-877-624-9769 ext. 100